PFE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 33 | |
P/E GROWTH RATING 1..100 | 96 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CURE | PFE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 49% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 49% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 43% |
| MACD ODDS (%) | 2 days ago 88% | 2 days ago 44% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 51% |
| Advances ODDS (%) | 2 days ago 90% | 2 days ago 56% |
| Declines ODDS (%) | N/A | 22 days ago 59% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 52% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 57% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IYW | 203.28 | -0.07 | -0.03% |
| iShares US Technology ETF | |||
| SPXV | 74.69 | -0.07 | -0.10% |
| ProShares S&P 500® ex-Health Care | |||
| DLY | 14.76 | -0.04 | -0.27% |
| DoubleLine Yield Opportunities Fund | |||
| SVIX | 20.22 | -0.13 | -0.64% |
| -1x Short VIX Futures ETF | |||
| AGIX | 37.15 | -0.50 | -1.33% |
| KraneShares Artfcl Intllgnc and Tech ETF | |||
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +4.12% | ||
| TMO - CURE | 72% Closely correlated | +0.26% | ||
| IQV - CURE | 71% Closely correlated | +1.08% | ||
| A - CURE | 68% Closely correlated | +1.41% | ||
| PFE - CURE | 68% Closely correlated | +1.41% | ||
| MTD - CURE | 67% Closely correlated | +0.19% | ||
More | ||||
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with BIIB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then BIIB could also see price increases.
| Ticker / NAME | Correlation To PFE | 1D Price Change % | ||
|---|---|---|---|---|
| PFE | 100% | +1.41% | ||
| BIIB - PFE | 65% Loosely correlated | +1.20% | ||
| AMGN - PFE | 63% Loosely correlated | -0.64% | ||
| BMY - PFE | 60% Loosely correlated | +0.74% | ||
| NVS - PFE | 60% Loosely correlated | +1.37% | ||
| AZN - PFE | 59% Loosely correlated | -1.58% | ||
More | ||||